Merck & Co., Inc.
$147.15
$2.24 (+1.55%)
$145.32Day Range$147.65
Key Statistics
Market Cap
$357.52B
Shares Outstanding
2,467.2M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Apr 20, 1949
Round Lot
100
Locale
US
Trading Data
Day Open
$145.74
Day High
$147.65
Day Low
$145.32
Volume
11.06M
VWAP
$146.89
Prev Close
$144.91
Transactions
--
Acc. Volume
--
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
PHARMACEUTICAL PREPARATIONSSIC 283475,000 employees126 EAST LINCOLN AVENUE, RAHWAY, NJ, 07065908-740-4000IPO Apr 20, 1949US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000310158
- Composite FIGI
- BBG000BPD168
- Share Class FIGI
- BBG001S5TC52
- Ticker Root
- MRK
- SIC Code
- 2834
About Merck & Co., Inc. (MRK) Stock
Merck & Co., Inc. (MRK) closed the 2026-09-17 session at $147.15, up 1.55% versus the previous close (+2.24). The stock opened at $145.74 and traded between $145.32 and $147.65 during that session. Session trading volume was 11.1M shares. The volume-weighted average price (VWAP) is $146.89.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Merck & Co., Inc. has a market capitalization of $357.52 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. MRK is listed on the XNYS exchange. The company employs approximately 75,000 people. Merck & Co., Inc. is headquartered in RAHWAY, NJ. The recorded listing date is 1949-04-20.
On this page you can find market MRK stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.